Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics data

Wentian Guo; Hui Li; Yitan Zhu; Li Lan; Shengjie Yang; Karen Drukker; Elizabeth A. Morris M.D.; Elizabeth S. Burnside M.D.; Gary J. Whitman M.D.; Maryellen L. Giger; Yuan Ji; TCGA Breast Phenotype Research Group

doi:10.1117/1.JMI.2.4.041007

23 September 2015 Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics data

Wentian Guo, Hui Li, Yitan Zhu, Li Lan, Shengjie Yang, Karen Drukker, Elizabeth A. Morris M.D., Elizabeth S. Burnside M.D., Gary J. Whitman M.D., Maryellen L. Giger, Yuan Ji, TCGA Breast Phenotype Research Group

Author Affiliations +

Journal of Medical Imaging, Vol. 2, Issue 4, 041007 (September 2015). https://doi.org/10.1117/1.JMI.2.4.041007

Abstract

Genomic and radiomic imaging profiles of invasive breast carcinomas from The Cancer Genome Atlas and The Cancer Imaging Archive were integrated and a comprehensive analysis was conducted to predict clinical outcomes using the radiogenomic features. Variable selection via LASSO and logistic regression were used to select the most-predictive radiogenomic features for the clinical phenotypes, including pathological stage, lymph node metastasis, and status of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Cross-validation with receiver operating characteristic (ROC) analysis was performed and the area under the ROC curve (AUC) was employed as the prediction metric. Higher AUCs were obtained in the prediction of pathological stage, ER, and PR status than for lymph node metastasis and HER2 status. Overall, the prediction performances by genomics alone, radiomics alone, and combined radiogenomics features showed statistically significant correlations with clinical outcomes; however, improvement on the prediction performance by combining genomics and radiomics data was not found to be statistically significant, most likely due to the small sample size of 91 cancer cases with 38 radiomic features and 144 genomic features.

Citation Download Citation

Wentian Guo, Hui Li, Yitan Zhu, Li Lan, Shengjie Yang, Karen Drukker, Elizabeth A. Morris M.D., Elizabeth S. Burnside M.D., Gary J. Whitman M.D., Maryellen L. Giger, Yuan Ji, and TCGA Breast Phenotype Research Group "Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics data," Journal of Medical Imaging 2(4), 041007 (23 September 2015). https://doi.org/10.1117/1.JMI.2.4.041007

Published: 23 September 2015

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available